- Home
- OSW vs TYRA Comparison
OSW vs TYRA Comparison
Compare OSW & TYRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OSW | TYRA |
|---|---|---|
| Founded | 2017 | 2018 |
| Country | Bahamas | United States |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.0B |
| IPO Year | 2019 | 2021 |
Fundamental Metrics
Financial Performance| Metric | OSW | TYRA |
|---|---|---|
| Price | $25.29 | $33.95 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 11 |
| Target Price | $27.00 | ★ $47.50 |
| AVG Volume (30 Days) | 759.5K | ★ 997.4K |
| Earning Date | 04-29-2026 | 05-06-2026 |
| Dividend Yield | ★ 0.81% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.21 | N/A |
| Revenue | ★ $961,001,000.00 | N/A |
| Revenue This Year | $7.49 | N/A |
| Revenue Next Year | $8.52 | N/A |
| P/E Ratio | $114.81 | ★ N/A |
| Revenue Growth | ★ 7.37 | N/A |
| 52 Week Low | $18.19 | $8.75 |
| 52 Week High | $25.75 | $40.65 |
Technical Indicators
Market Signals| Indicator | OSW | TYRA |
|---|---|---|
| Relative Strength Index (RSI) | 57.55 | 43.03 |
| Support Level | $19.70 | $33.81 |
| Resistance Level | $25.25 | $33.99 |
| Average True Range (ATR) | 0.93 | 2.25 |
| MACD | -0.04 | -0.28 |
| Stochastic Oscillator | 79.20 | 16.55 |
Price Performance
Historical ComparisonAbout OSW OneSpaWorld Holdings Limited
OneSpaWorld Holdings Ltd is an operator of health and wellness centers onboard cruise ships and an operator of health and wellness centers at destination resorts all over the world. It offers a suite of premium health, fitness, beauty, and wellness services and products. The services provided by the company include body, salon, and skin care services and products, fitness classes and personal fitness training and pain management, detoxifying programs, and comprehensive body composition analyses among others. The company has only one single segment of Maritime and Destination Resorts.
About TYRA Tyra Biosciences Inc.
Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines for large opportunities in targeted oncology and genetically defined conditions, harnessing the power of Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are FGFR3, FGFR4/3, and FGFR1/2/3: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.